Drug Trial Radar · NCT00129142
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
Last checked: Nov 20, 2026Latest source record: Nov 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,200
Actual
Start
Oct 2003
Primary completion
Nov 2007
Study completion Nov 2007
Sponsor
- Lead sponsor
- GTxIndustry
- Sponsor type
- Industry
- First posted
- Aug 11, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double
- Primary purpose
- Prevention
- Who can join
- Male only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Androgen deprivation therapy (ADT) treatment for prostate cancer decreases the natural hormone called testosterone. This type of therapy is very effective for the treatment of prostate cancer. However, one of the side effects is bone loss or thinning of the bones that can lead to osteoporosis and an increased risk of bone fractures (breaking of the bones). The purpose of the study is to determine whether or not the addition of toremifene citrate (the study drug) to therapy can prevent or decrease the number of bone fractures and to evaluate its impact on side effects associated with testosterone reduction therapy.
Conditions
- Prostate Cancer
- Osteoporosis
- Fractures
Interventions
Toremifene CitrateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of subjects at 24 months with at least one new vertebral fracture determined by blinded central review of radiographs of the thoracic and lumbar spine
Locations
155 sites in 2 countries. Site status is shown where the registry gives one.
Urology Centers of Alabama
Homewood, Alabama
Coastal Clinical Research
Mobile, Alabama
Arkansas Urology
Little Rock, Arkansas
Advanced Urology Medical Center Clinical Trials
Anaheim, California
Urological Sciences Research Foudation
Culver City, California
Urological Associates of Central CA
Fresno, California
Center of Urologic Research
La Mesa, California
South Orange County Medical Research Center
Laguna Woods, California
Palo Alto VA
Palo Alto, California
San Bernadino Urological Associates
San Bernadino, California
Urological Physicians of San Diego
San Diego, California
Veterans Medical Research Foundation
San Diego, California
Pacific Clinical Research
Santa Monica, California
West Coast Clinical Research
Tarzana, California
Western Clinical Research, Inc.
Torrance, California
Urology Associates
Denver, Colorado
Western Urological Research
Wheat Ridge, Colorado
Urologic Center
New Haven, Connecticut
Urological Associates of Bridgeport
Trumball, Connecticut
Connecticut Clinical Research
Waterbury, Connecticut
Walter Reed Army Medical Center
Washington D.C., District of Columbia
South Florida Medical Research
Aventura, Florida
Urology Consultants Inc.
Clearwater, Florida
Atlantic Urological Associates
Daytona Beach, Florida
Urosearch
Inverness, Florida
Lakeland Regional Medical Center
Lakeland, Florida
Advance Research Institute
New Port Richey, Florida
Central Florida Urology Group/ UroSearch
Ocala, Florida
Florida Foundation for Healthcare Research
Ocala, Florida
Winter Park Urology Associates
Orlando, Florida
Panama City Urology
Panama City Beach, Florida
Pinellas Urology
St. Petersburg, Florida
Southeastern Research Group
Tallahassee, Florida
Tampa Bay Urology
Tampa, Florida
UroSearch
Tavares, Florida
Cleveland Clinic-Florida
Weston, Florida
Midtown Urology
Atlanta, Georgia
Georgia Urology
Atlanta, Georgia
St. Joseph Research Institute
Atlanta, Georgia
Augusta VAMC
Augusta, Georgia
Showing 40 of 155 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.